Dr. Roxana Redis earned her Ph.D. from the University of Medicine and Pharmacy, Cluj-Napoca, RO in 2013. Her work focused on deciphering the involvement of non-codingRNAs in cancer initiation and progression and it was performed in collaboration with the Erasmus MC in Rotterdam, NL.
Already during her Ph.D. studies, she joined Dr. George Calin’s laboratory at M.D. Anderson Cancer Center in Houston, U.S.A. and continued as a postdoctoral
fellow researching in depth the mechanisms of action of long and short non-coding RNAs in oncology. In 2016, Dr Redis joined ProQR Therapeutics N.V in Leiden, NL as a scientist.
ProQR is a biotech company focused on development of drugs to treat severe genetic disorders. Today, she is a senior scientist working on the development of a novel proprietary RNA editing technology - Axiomer® technology.